Calabrese S, Giansante C, Oselladore F, Benedetti A, Mitri E
Minerva Med. 1983 May 31;74(22-23):1357-63.
Thirty-five patients affected by acute vestibular dysfunction (A.V.D.) and/or sudden deafness (S.D.) were studied. Twenty-seven of them presented, as major component of the clinical disorder, a vestibular dysfunction, eight a sudden deafness. The control group was matched for sex, age, smoking habit and family history of diabetes and myocardial infarction. In all the subjects the following tests were carried out: platelet aggregation (Born's method), PF3 (Spaet and Cintron), PF4 and BTg (RIA), aPTT, AT III, cholesterol and triglycerides. The results indicate in the patients group increase of P.A.: SAV = 27 vs 43% (p = 0.03) at 1.2 X 10(-6) M ADP, a larger availability of PF3 in PPP and PRP, increase of PF4: 7.2 vs 17.2 (p = 0.01) and BTg: 32.4 vs 49.1 (p = 0.009). The data indicate in A.V.D. and S.D. a platelet hyperactivity; if so, an antiplatelet therapy may be reasonable.
对35例患有急性前庭功能障碍(A.V.D.)和/或突发性耳聋(S.D.)的患者进行了研究。其中27例以前庭功能障碍为临床疾病的主要组成部分,8例为突发性耳聋。对照组在性别、年龄、吸烟习惯以及糖尿病和心肌梗死家族史方面进行了匹配。对所有受试者进行了以下检查:血小板聚集(博恩氏法)、PF3(斯佩特和辛特龙法)、PF4和BTg(放射免疫分析法)、活化部分凝血活酶时间(aPTT)、抗凝血酶III(AT III)、胆固醇和甘油三酯。结果表明,在患者组中,血小板聚集增加:在1.2×10⁻⁶M二磷酸腺苷(ADP)时,SAV = 27%对43%(p = 0.03),血小板第三因子(PF3)在血小板血浆(PPP)和富血小板血浆(PRP)中的可用性更高,PF4增加:7.2对17.2(p = 0.01),BTg增加:32.4对49.1(p = 0.009)。数据表明在急性前庭功能障碍和突发性耳聋中存在血小板活性过高的情况;如果是这样,抗血小板治疗可能是合理的。